Exact Mass: 327.0612
Exact Mass Matches: 327.0612
Found 289 metabolites which its exact mass value is equals to given mass value 327.0612,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluazifop
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Etaconazole
Robenacoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
deoxyviolacein
A member of the class of oxindoles resulting from formal oxidative coupling between the 3-position of 1,3-dihydro-2H-indol-2-one and the 3-position of 1,3-dihydro-2H-pyrrol-2-one, which is substituted at the 5 position by a 1H-indol-3-yl group, where the newly-formed double bond has E configuration.
Acetaminophen glucuronide
Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Acetaminophen glucuronide is found to be associated with beta-thalassemia, which is an inborn error of metabolism. Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB]
N-(4-Hydroxycinnamoyl)tyrosine
Natural food antioxidant. Isolated from cocoa liquor (Theobroma cacao). N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products and cocoa powder. N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products. Natural food antioxidant. It is isolated from cocoa liquor (Theobroma cacao).
Blepharin
Glycoside from seedlings of rye and sweet corn (Zea mays). Blepharin is found in cereals and cereal products, fats and oils, and corn. Blepharin is found in cereals and cereal products. Blepharin is a glycoside from seedlings of rye and sweet corn (Zea mays
(2S,3S,4S,5R)-6-(4-Acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-
(5S)-5-(7-Benzofuranyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol
Robenacoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
3-methylthiopropyl-desulfoglucosinolate
3-methylthiopropyl-desulfoglucosinolate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 3-methylthiopropyl-desulfoglucosinolate can be found in a number of food items such as caraway, lemon thyme, wakame, and papaya, which makes 3-methylthiopropyl-desulfoglucosinolate a potential biomarker for the consumption of these food products.
4-coumaroyl-4'-hydroxyphenyllactate
4-coumaroyl-4-hydroxyphenyllactate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4-coumaroyl-4-hydroxyphenyllactate can be found in a number of food items such as sourdock, summer savory, hazelnut, and thistle, which makes 4-coumaroyl-4-hydroxyphenyllactate a potential biomarker for the consumption of these food products.
Aristolochic acid C
Aristolochic acid C is an aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, and by a nitro group at position 10. It has a role as a carcinogenic agent, a metabolite, a mutagen, a nephrotoxin and a toxin. It is a C-nitro compound, a member of aristolochic acids, an aromatic ether, a cyclic acetal, a monocarboxylic acid and an organic heterotetracyclic compound. Aristolochic acid C is a natural product found in Aristolochia kaempferi, Aristolochia kankauensis, and other organisms with data available. An aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, and by a nitro group at position 10. Annotation level-1 Aristolochic acid C is a derivative of Aristolochic acid. Aristolochic acid is a phospholipase A2 (PLA2) inhibitor, which disrupts cortical microtubule arrays and root growth in Arabidopsis[1].
1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-4-((3-methyl-2-butenyl)oxy)-
(S,E)-2-(3-(3,4-dihydroxyphenyl)acrylamido)-3-phenylpropanoic acid|2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-phenylpropionic acid|N-trans-caffeoyl-L-phenylalanine
1-(2-hydroxy-4-methoxyphenylamino)-1-deoxy-beta-D-glucopyranoside-1,2-carbamate
8-Hydroxy-5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone
proviolacein
A hydroxyindole that is 2H-pyrrol-2-one which is substituted at positions 3 and 5 by 1H-indol-3-yl and 5-hydroxy-1H-indol-3-yl groups, respectively. It is an intermediate in the biosynthesis of the purple chromobacterial pigment violacein from L-tryptophan.
O1-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-beta-D-glucopyranuronic acid|O1-(2-Oxo-2,3-dihydro-benzoxazol-6-yl)-beta-D-glucopyranuronsaeure
(E) methyl 2-[2-oxo-1-(2,3,5-trihydroxyphenyl)-1,2-dihydro-3H-indol-3-ylidene]acetate|costinone A
(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-2-(4-hydroxyphenyl)ethan-1-imine
Fluazifop
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 147 EAWAG_UCHEM_ID 147; CONFIDENCE standard compound
C18H17NO5_L-Tyrosine, N-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
C18H17NO5_L-Tyrosine, N-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
Tranilast
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents Tranilast (MK-341) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects[1]. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells[2]. trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis. Target: Angiotensin Receptor Tranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation in vitro and also suppressed collagen production both in vitro and in vivo . Tranilast also reduced the release of chemical mediators from mast cells and suppressed hypersensitivity reactions. [1] Three-week-old C57Bl/10 and mdx mice received tranilast (~300 mg/kg) in their food for 9 weeks, after which fibrosis was assessed through histological analyses, and functional properties of tibialis anterior muscles were assessed in situ and diaphragm muscle strips in vitro. Tranilast administration did not significantly alter the mass of any muscles in control or mdx mice, but it decreased fibrosis in the severely affected diaphragm muscle by 31\% compared with untreated mdx mice (P< 0.05) [2].
(2S)-3-(4-hydroxyphenyl)-2-[[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propanoic acid
DICLOBUTRAZOL
PC(2:0/1:0)[U]
Isradipine Metabolite (3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-, mo
5-Chloro-2-(3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl)benzophenone
N-trans-P-Coumaroyltyrosine
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate
3-[3-(4-methoxyphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
3-chloro-4-(dimethylamino)benzenediazonium,hexafluorophosphate
2-(3,4-DIMETHOXYBENZYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID
1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile
Benzenesulfonamide,4-methoxy-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-
2-CBZ-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid
8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-3A,4-DIHYDRO-3H-BENZO[F]IMIDAZO[1,5-A][1,4]DIAZEPINE
2H-1-Benzopyran-2-one,7-(diethylamino)-3-(2-thienylcarbonyl)-
tert-butyl 3-bromo-5-fluoro-2-methylindole-1-carboxylate
4-(4-bromophenyl)-1,2,36-tetrahydro-1-(phenylmethyl)-pyridine
1-(5-Methyl-benzo[1,2,5]thiadiazole-4-sulfonyl)-pyrrolidine-2-carboxylic acid
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxoquinoline-3-carboxylate
1-NAPHTHALENAMINE, 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-, HYDROCHLORIDE, (1R,4R)-
tert-butyl 9-bromo-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate
Cytidine 2,3-cyclic phosphate
Cytidine 2,3-cyclic phosphate is a cytidine nucleotide containing a pyrophosphate group esterified to C2 and C3(cyclic) of the sugar moiety. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. 2,3 cyclic CMP is a substrate for 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. CNP is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. The biological role of cyclic 2,3 monophosphates is not clear, although it is thought to have something to do with neuronal stasis or development. [HMDB]
Ranimustine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
(1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE
[2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl]propanedioic acid dimethyl ester
Ammonium ((1S,3R,4R,7S)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate
2-(1,3-DIOXOISOINDOLIN-2-YL)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-7-CARBONITRILE
(5-BROMO-2-(DIISOPROPYLCARBAMOYL)PHENYL)BORONIC ACID
5-(Chloroacetyl)-8-(phenylmethoxy)-2(1H)-quinolinone
Thiamine nitrate
D018977 - Micronutrients > D014815 - Vitamins Thiamine nitrate is an essential vitamin which can enhance normal neuronal actives.
7-AMINO-4-(PYRIDINE-2-YL-METHYL)-1,4-BENZOXAZIN-3(4H)-ONEDIHYDROCHLORIDE
6-Chloro-4-nitro-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrrolo[2,3-b]pyridine
7-(4-methylsulfanylphenyl)-5-thiophen-2-yl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
Fasudil Hydrochloride
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
N-(3-CHLOROPHENYL)-2-(5-(P-TOLYL)-1,2,4-OXADIAZOL-3-YL)ACETAMIDE
4-[2-(DIMETHYLAMINO)ETHYL]PIPERAZINE-1-CARBOXIMIDAMIDE HYDROIODIDE
(3-(2-Nitro-4-(trifluoromethyl)phenoxy)phenyl)boronic acid
4-[4-(1-bromoethyl)-2-cyclopropylpyrimidin-5-yl]benzonitrile
5-(4-IODO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
6-[(2-chloroquinolin-3-yl)methyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one
7-BENZYL-4-CHLORO-2-(TRIFLUOROMETHYL)-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDINE
[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylsulphonyl)phenyl]boronic acid
methyl5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazole-4-carboxylate
Verosudil
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Methyl 4,6-O-[(S)-(4-nitrophenyl)methylene]-alpha-D-galactopyranoside
7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydrochromene-2,5-dione
(4-(2-NITRO-4-(TRIFLUOROMETHYL)PHENOXY)PHENYL)BORONIC ACID
(4-(N-(Naphthalen-1-yl)sulfamoyl)phenyl)boronic acid
4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-2(3H)-one 4-methylbenzenesulfonate
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride
2-[(5-Chloro-1-benzothiophen-3-yl)methyl]-1H-isoindole-1,3(2H)-di one
6-(2-Fluorobenzyl)-2,4-Dimethyl-4,6-Dihydro-5h-Thieno[2,3:4,5]pyrrolo[2,3-D]pyridazin-5-One
4-Methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-YL)benzenesulfonamide
(+)-5-(7-benzofuranyl)-8-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol
1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-
Methyl 3-[5-(anilinocarbonyl)-2-furyl]-2-thiophenecarboxylate
5-(2-chlorophenyl)-N-(4-methoxyphenyl)-2-furancarboxamide
2-[(4-cyano-1-oxo-5H-pyrido[1,2-a]benzimidazol-3-yl)methylthio]propanoic acid
6-amino-1-(4-chlorophenyl)-2-oxo-4-(1H-1,2,4-triazol-1-ylmethyl)-1,2-dihydro-5-pyrimidinecarbonitrile
1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)ethanone
2-(2,6-Difluorophenyl)-3-(5-ethyl-1,3,4-thiadiazol-2-yl)thiazolidin-4-one
ethyl N-[(2Z)-2-cyano-2-{[(2,4-dichlorophenyl)amino]methylidene}acetyl]carbamate
4-[3-Methylsulfanylanilino]-6,7-dimethoxyquinazoline
1-(2-Deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4-methyl-1H-indole
5-(Acetylamino)-3,5-Dideoxy-3-Fluoro-D-Erythro-Alpha-L-Manno-Non-2-Ulopyranosonic Acid
6-Hydroxymelatoninsulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
pyrano[3,2-a]xanthen-12(1H)-one, 2,3-dihydro-5,9,11-trihydroxy-3,3-dimethyl-
2-[[(2R)-2-amino-3-[(Z)-N-hydroxy-C-[(4-hydroxyphenyl)methyl]carbonimidoyl]sulfanylpropanoyl]amino]acetic acid
[(2R,3S,4R,5R)-5-(4-amino-5-nitro-1H-imidazol-3-ium-3-yl)-3,4-dihydroxyoxolan-2-yl] dihydrogen phosphate
3-(4-hydroxyphenyl)-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxypropanoate
[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-N-hydroxy-4-methylsulfanylbutanimidothioate
1-[4-Amino-3-[2-(1-pyrrolidinyl)ethylthio]-5-thieno[2,3-c]isothiazolyl]ethanone
3-[(4-methoxybenzylidene)amino]-2,5,6-trimethylthieno[2,3-d]pyrimidin-4(3H)-one
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide
4-(3,4-dimethoxyphenyl)-N-(3-methyl-2-pyridinyl)-2-thiazolamine
4-phenyl-3-[2-(phenylmethylthio)ethyl]-1H-1,2,4-triazole-5-thione
1-Hydroxy-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid thiazol-2-ylamide
N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
8-[2-(4-Chloro-3,5-dimethylphenoxy)ethoxy]quinoline
8-[2-(4-Chloro-2,5-dimethylphenoxy)ethoxy]quinoline
[(E)-[5-[4-(difluoromethylsulfanyl)phenyl]furan-2-yl]methylideneamino]thiourea
4-Hydroxy-2-oxo-1-(prop-2-en-1-yl)-N-(1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide
2-[(3-ethyl-2-quinolinyl)thio]-N-(5-methyl-3-isoxazolyl)acetamide
2-(4-chlorophenyl)-N-[4-(difluoromethylthio)phenyl]acetamide
5-(2,5-difluorophenyl)-N-(2,6-dimethylphenyl)-2-furancarboxamide
3-(4-methoxyphenyl)-3-(1-pyrrolyl)-N-(2-thiazolyl)propanamide
5-tert-butyl-N-[4-(triluoromethyl)phenyl]thiophene-2-carboxamide
N-(3-methoxyphenyl)-N-[6-oxo-4-(trifluoromethyl)-1,6-dihydro-2-pyrimidinyl]guanidine
3,5-dimethyl-N-[4-(trifluoromethyl)benzoyl]isoxazole-4-carbohydrazide
(3Z)-3-[(3-acetyl-4-hydroxy-2-imino-1,3-thiazol-5-yl)methylidene]-7-methylquinolin-2-one
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-N-hydroxy-4-methylsulfanylbutanimidothioate
(E)-1-(4-fluorophenyl)-N-[5-(4-methoxyphenyl)-4H-1,3,4-thiadiazin-2-yl]methanimine
3-methylbut-2-enyl [(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate
(2Z,5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-pyridin-2-ylimino-1,3-thiazolidin-4-one
(5Z)-3-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methylidene]-5-oxo-2,5-dihydrofuran-3-olate
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-propanoyloxypropyl] propanoate
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] butanoate
acetaminophen O-beta-D-glucosiduronic acid
A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen).
6-amino-1-(4-chlorophenyl)-2-oxo-4-(1,2,4-triazol-1-ylmethyl)-5-pyrimidinecarbonitrile
2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid
M1001
M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research[1].
(1s,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one
n-[(1z,3e)-1,4-bis(3,4-dihydroxyphenyl)-3-methylbuta-1,3-dien-2-yl]carboximidic acid
3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol
(2r)-3-(3-chloro-4-hydroxyphenyl)-2-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propanoic acid
12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one
3,8-dihydroxy-1,10-dimethyl-7h-5-oxa-12-thia-7-azatetraphen-6-one
(1s,2r)-1,2,9-trihydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde
3-[(3z)-2-hydroxy-5-(1h-indol-3-yl)pyrrol-3-ylidene]indol-2-ol
(1s,11r,19r)-11-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-14-one
(2e,4e)-n-[2-(4-hydroxy-6-oxopyran-2-yl)ethyl]-5-(4-hydroxyphenyl)penta-2,4-dienimidic acid
(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enimidic acid
3-methoxy-4-hydroxyphenol
{"Ingredient_id": "HBIN008804","Ingredient_name": "3-methoxy-4-hydroxyphenol","Alias": "NA","Ingredient_formula": "C16H13N3O5","Ingredient_Smile": "COC1=NC(=C2C=CC(=O)C=C2O)NC(=C3C=CC(=O)C=C3O)N1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40185","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bisindolylpyrrole cpb-53-594-6
{"Ingredient_id": "HBIN018627","Ingredient_name": "bisindolylpyrrole cpb-53-594-6","Alias": "NA","Ingredient_formula": "C20H13N3O2","Ingredient_Smile": "C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2476","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
